HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Veterinary Medicines
  • >CMDv
  • >Procedural guidance
  • >Miscellaneous
  • CMDv
    • About CMDv
    • Implementation of the VMP Regulation
    • BREXIT
    • Advice from CMDv
    • Procedural Contact Points
    • Procedural guidance
      • General Information on Applications
      • Validation of Applications
      • Applications for Marketing Authorisation
      • Post Marketing Procedures
      • CMDv Review Procedure and Referrals
      • Re-examination after DCP/VRA
      • Parallel trade
      • SPC Harmonisation
      • ASMF
      • SPC, Labelling and Package leaflet
      • Borderline products
      • Clinical trials
      • Miscellaneous
    • Questions & Answers
    • Publications
    • Union Product Database (UPD)
  • VMRI Product Index
  • National Contacts

 

Miscellaneous

Special Veterinary Medicinal Products

Bee products available in Europe

Veterinary Medicinal Products intended for fish

 

Immunological products

Solvents - Conclusions and recommendations

Recommendations for the manufacture, control and use of inactivated autogenous veterinary vaccines within the EEA

CMDv position paper on the implementation of the revision of Ph. Eur. regarding testing for extraneous agents

 

Additional information

Best practice guide for collaboration between Member States in relation to GMP non-compliance issues and CEP withdrawals due to GMP non-compliance issues

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/veterinary-medicines/cmdv/procedural-guidance/miscellaneous.html